Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",hepatocyte apoptosis trait,,RS:0000427,F344/Seac,male,84 days,6,,CMO:0001098,TUNEL-positive cell number to total cell number ratio,,tunel hepatocytes to total hepatocytes ratio,,1.3,%,0.3266,0.8,MMO:0000220,ex vivo light microscopy with digital image analysis,liver,0.0,,,56,days,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67545,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",hepatocyte apoptosis trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,84 days,6,,CMO:0001098,TUNEL-positive cell number to total cell number ratio,,tunel hepatocytes to total hepatocytes ratio,,2.9,%,0.6124,1.5,MMO:0000220,ex vivo light microscopy with digital image analysis,liver,0.0,,,56,days,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67547,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",hepatocyte apoptosis trait,,RS:0000249,DRH/Seac,male,84 days,6,,CMO:0001098,TUNEL-positive cell number to total cell number ratio,,tunel hepatocytes to total hepatocytes ratio,,57.9,%,2.9802,7.3,MMO:0000220,ex vivo light microscopy with digital image analysis,liver,0.0,,,56,days,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67548,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,84 days,6,,CMO:0001094,area of liver occupied by fibrotic lesions to total liver area ratio,,,,11.3,%,1.1839,2.9,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67433,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000249,DRH/Seac,male,84 days,6,,CMO:0001094,area of liver occupied by fibrotic lesions to total liver area ratio,,,,5.7,%,0.3266,0.8,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67434,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000427,F344/Seac,male,84 days,6,,CMO:0001094,area of liver occupied by fibrotic lesions to total liver area ratio,,,,17.9,%,1.3472,3.3,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67432,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000427,F344/Seac,male,84 days,6,,CMO:0001074,area of liver occupied by tumorous lesions as percentage of total liver area,,per 40X field,,44.2,%,2.1229,5.2,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67414,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,84 days,6,,CMO:0001074,area of liver occupied by tumorous lesions as percentage of total liver area,,per 40X field,,12.6,%,1.1431,2.8,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67415,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000249,DRH/Seac,male,84 days,6,,CMO:0001074,area of liver occupied by tumorous lesions as percentage of total liver area,,per 40X field,,3,%,0.6532,1.6,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67416,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000427,F344/Seac,male,84 days,6,,CMO:0001071,area of individual liver tumorous lesion,,,,0.08,mm2,0.0082,0.02,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67429,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,84 days,6,,CMO:0001071,area of individual liver tumorous lesion,,,,0.02,mm2,0.0024,0.006,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67430,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000249,DRH/Seac,male,84 days,6,,CMO:0001071,area of individual liver tumorous lesion,,,,0.007,mm2,0.0016,0.004,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67431,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000427,F344/Seac,male,84 days,6,,CMO:0001210,liver tumorous lesion number to liver area ratio,,/40x field,,6036.0985824,/cm2,693.0638,1697.6527,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67402,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,84 days,6,,CMO:0001210,liver tumorous lesion number to liver area ratio,,/40x field,,5407.3383134,/cm2,359.3664,880.2644,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67407,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) 750,"Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9.",liver integrity trait,,RS:0000249,DRH/Seac,male,84 days,6,,CMO:0001210,liver tumorous lesion number to liver area ratio,,/40x field,,1571.9006725,/cm2,205.3522,503.0082,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days),67408,controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days)